What Is the DEA Cannabis Classification?
The DEA classifies cannabis as a Schedule I controlled substance under the federal Controlled Substances Act. Schedule I is the most restrictive tier in the DEA system, reserved for drugs the federal government says carry a high potential for abuse, no accepted medical use in the United States, and no accepted safety profile for use under medical supervision. Cannabis has held that spot since the Controlled Substances Act took effect in 1970, and the federal status still stands.
cannabis dea news rescheduling 2024
That single label shapes tax rules, banking access, research, and the gap between state-legal cannabis and federal law. The DEA proposed moving cannabis to Schedule III in May 2024, but no final rule has been issued.
cannabis dea news rescheduling 2024
What Does Schedule I Mean in Practice?
Drugs in Schedule I cannot be prescribed through normal channels, and pharmacies cannot dispense them. For cannabis businesses and consumers, that shows up in concrete ways:
Cannabis DEA Federal Lawsuit Update: What You Need to Know
- State-licensed dispensaries operate under state law, not federal permission.
- Section 280E of the federal tax code blocks cannabis companies from deducting ordinary business expenses.
- Most banks and card networks avoid the industry because of federal money laundering exposure.
- Researchers need a DEA registration and a DEA-approved supply to study cannabis, which slows clinical work.
How Do the DEA Schedules Compare?
The Controlled Substances Act sorts controlled drugs into five schedules based on abuse potential and accepted medical use.
- Schedule I: no accepted medical use, high abuse potential. Examples: heroin, LSD, MDMA, cannabis.
- Schedule II: accepted medical use with tight controls. Examples: oxycodone, morphine, amphetamine.
- Schedule III: less abuse potential than I and II, with moderate to low physical dependence. Examples: ketamine, anabolic steroids, codeine combination products.
- Schedule IV: lower abuse potential. Examples: alprazolam, diazepam, zolpidem.
- Schedule V: lowest abuse potential. Examples: cough syrups with small amounts of codeine.
Is the DEA Changing the Cannabis Classification?
In May 2024, the DEA published a proposed rule to move marijuana from Schedule I to Schedule III. The proposal followed a 2023 review by the Department of Health and Human Services, which recommended rescheduling. A proposed rule does not change the law on its own.
The process includes a public comment period and an administrative hearing before a DEA judge. Until a final order publishes, the answer to what schedule cannabis is in remains Schedule I.
What would Schedule III change?
Schedule III would keep cannabis controlled but recognize medical use at the federal level. The biggest practical shift is Section 280E: that tax penalty applies to Schedule I and II drugs, so cannabis companies could deduct ordinary expenses if the change takes effect.
Federal penalties for possession without a prescription would drop, though such possession would remain illegal. Medical cannabis could become a recognized federal medicine category. Adult-use retail would stay outside federal law.
Who decides the schedule of a drug?
The DEA sets schedules through rulemaking under the Controlled Substances Act, with medical and scientific input from HHS and the FDA. Congress can also act, and it has moved drugs between schedules before.
Does the DEA Classification Override State Cannabis Laws?
No. States cannot legalize something federal law prohibits; they can only remove their own state penalties. That is why a licensed shop can sell flower in a legal state while the same product stays illegal under federal law.
Federal prosecutors have brought few cases against state-compliant operators since 2013 guidance, but that restraint is policy, not a legal shield. Federal law still applies on federal land, at ports of entry, and in interstate commerce.
Where Does Hemp Fit in the DEA Classification?
Hemp is cannabis, but the 2018 Farm Bill removed it from the Controlled Substances Act. Hemp is defined as cannabis with delta-9 THC at or below 0.3 percent on a dry weight basis.
Cross that threshold and the plant counts as marijuana under federal law. Delta-8 THC products made from hemp sit in a gray area, and several states have moved to ban them.
CBD is not scheduled on its own, and the FDA-approved CBD medicine Epidiolex was removed from DEA control in 2020. The FDA has not approved CBD as a dietary supplement, so the legal picture varies by state.
FAQ: DEA Cannabis Classification
What schedule is cannabis in under the DEA?
Schedule I, the same tier as heroin and LSD. It has held that classification since 1970.
Is marijuana still a Schedule I drug?
Yes. A final DEA rule moving cannabis to Schedule III would change that, and the May 2024 proposal alone does not.
Does rescheduling legalize cannabis?
No. Schedule III still means federal control. A prescription-based medical system could emerge, but recreational sales would stay illegal under federal law.
Can states ignore the DEA classification?
States can pass their own laws, and about two dozen have legalized adult use. Federal law still applies, and state law cannot erase it.
Does the DEA classification affect medical cannabis patients?
It does. Patients in state medical programs are protected by state law only, and a federal change to Schedule III could open the door to federal prescriptions and insurance coverage.